Thalidomide: all 323 studies that test it

Page 1 of 4. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• The Efficacy of CAPCT in Patients With PTCLNot yet recruitingNCT07746245Phase 2
• Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta ThalassemiaRecruitingNCT07673302Not applicable
• Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid TumorsRecruitingNCT07671534Phase 2
• Efficacy and Safety of Thalidomide for Pediatric PFAPA SyndromeNot yet recruitingNCT07476625Not applicable
• A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07309419Phase 2/3
• Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCHRecruitingNCT07187193Phase 2
• Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary DiseaseRecruitingNCT06793475Not applicable
• Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial)Not yet recruitingNCT06772480Not applicable
• Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.RecruitingNCT06617182Phase 2
• Thalidomide for the Symptomatic Large Granular Lymphocytic LeukemiaRecruitingNCT06530576Phase 2
• Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta ThalassemiaRecruitingNCT06490627Phase 2
• Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal CancerRecruitingNCT06279351Phase 2
• A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06276933Phase 4
• The Therapeutic Effect of Thalidomide in SyringomyeliaRecruitingNCT06268093Phase 2
• Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)RecruitingNCT06231680Phase 2
• Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic CancerRecruitingNCT06017284Phase 3
• Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMMRecruitingNCT04941937Phase 2
• TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLLRecruitingNCT04453345Phase 2/3
• A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLLRecruitingNCT03980002Phase 2
• Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune DiseasesCompletedNCT03122431Phase 4Results posted
• TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot TrialStatus unknownNCT03043105Phase 2Results posted
• A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL AmyloidosisCompletedNCT02545907Phase 1/2Results posted
• A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple MyelomaCompletedNCT02541383Phase 3Results posted
• Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165CompletedNCT02507336Phase 2Results posted
• Optimising Renal Outcome in Myeloma Renal FailureCompletedNCT02424851Phase 2Results posted
• Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)TerminatedNCT01927718Not applicableResults posted
• Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple MyelomaCompletedNCT01849783Phase 2Results posted
• Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom MacroglobulinemiaTerminatedNCT01779167Phase 2Results posted
• Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaCompletedNCT01632150Phase 2Results posted
• Velcade (Bortezomib) Consolidation After TransplantCompletedNCT01539083Phase 3Results posted
• Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCTCompletedNCT01242267Phase 1/2Results posted
• Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLLCompletedNCT01125176Phase 2Results posted
• Thalidomide Low Threshold in EpilepsyCompletedNCT01061866Phase 1/2Results posted
• Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple MyelomaCompletedNCT01057225Phase 1/2Results posted
• Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT00966693Phase 1/2Results posted
• Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular MalformationCompletedNCT00964496Phase 2Results posted
• Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)TerminatedNCT00953615Phase 2Results posted
• Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple MyelomaCompletedNCT00792142Phase 2Results posted
• Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00600028Phase 3Results posted
• Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple MyelomaTerminatedNCT00538824Phase 2Results posted
• Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple MyelomaCompletedNCT00538733Phase 2Results posted
• The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis PatientsTerminatedNCT00529633Phase 3Results posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple MyelomaCompletedNCT00523848Phase 2Results posted
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and PrednisoneCompletedNCT00507416Phase 3Results posted
• Biochemotherapy With Temozolomide for Metastatic MelanomaTerminatedNCT00505635Phase 2Results posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple MyelomaCompletedNCT00458705Phase 2Results posted
• R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedNCT00450801Phase 2Results posted
• Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple MyelomaCompletedNCT00432458Phase 3Results posted
• Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With GliomasCompletedNCT00412542Phase 2Results posted
• GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate CancerCompletedNCT00400517Phase 2Results posted
• The Effects of Thalidomide on Symptom ClustersCompletedNCT00379353Phase 2Results posted
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerCompletedNCT00357500Phase 2Results posted
• Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix CancerCompletedNCT00310076Phase 2Results posted
• Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)CompletedNCT00307294Phase 2Results posted
• Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple MyelomaCompletedNCT00287872Phase 2Results posted
• Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung CancerTerminatedNCT00281827Phase 2Results posted
• A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of LifeCompletedNCT00222105Phase 2Results posted
• Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)TerminatedNCT00215943Phase 3Results posted
• Thalidomide and Rituximab in Waldenstrom's MacroglobulinemiaCompletedNCT00142116Phase 2Results posted
• S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00124579Phase 2Results posted
• Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeCompletedNCT00112502Phase 2Results posted
• Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or NeuroblastomaCompletedNCT00098865Phase 2Results posted
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple MyelomaActive, not recruitingNCT00098475Phase 3Results posted
• Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00096018Phase 1/2Results posted
• PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTerminatedNCT00090870Phase 2Results posted
• DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE ConsolidationCompletedNCT00083915Phase 3Results posted
• UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation ChemotherapyCompletedNCT00083551Phase 3Results posted
• Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and ThalidomideCompletedNCT00083382Phase 2Results posted
• UARK 2003-33, Total Therapy IIICompletedNCT00081939Phase 2Results posted
• Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)CompletedNCT00075829Phase 3Results posted
• Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related StomatitisTerminatedNCT00075023Phase 2Results posted
• Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple MyelomaCompletedNCT00049673Phase 3Results posted
• Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent GliomasCompletedNCT00047879Phase 2Results posted
• Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00041080Phase 3Results posted
• S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00040937Phase 2Results posted
• Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the UterusCompletedNCT00025506Phase 2Results posted
• Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal CancerTerminatedNCT00019747Phase 2Results posted
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004859Phase 3Results posted
• Thalidomide for the Treatment of Hormone-Dependent Prostate CancerCompletedNCT00004635Phase 3Results posted
• Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple MyelomaCompletedNCT00004088Phase 2Results posted
• Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCHActive, not recruitingNCT07204041Phase 2
• Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia PatientsCompletedNCT06888232Not applicable
• Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff TendinopathyWithdrawnNCT06712290Not applicable
• Long Term Beta Thalassemia Treatment: Findings From The Extension PeriodActive, not recruitingNCT06490601Phase 2
• Efficacy of Combination of Hdroxyurea and Thalidomide Over Hydroxyurea or Thalidomide in the Treatment of Transfusion Dependent Thalassemia in ChildrenCompletedNCT06299670Phase 4
• Thalidomide and Hydroxyurea Combination in β-Thalassemia PatientsCompletedNCT06153784Phase 2/3
• Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia PatientsCompletedNCT06146478Phase 3
• Safety & Efficacy of Thalidomide in Children With Transfusion Dependent ThalassemiaCompletedNCT06098014Phase 1
• A Study of Thalidomide in the Treatment of Refractory Uremic PruritusStatus unknownNCT05525234Phase 4
• Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal CancerStatus unknownNCT05266820Phase 2
• Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GCStatus unknownNCT05198856Phase 1/2
• Clinical Experience of Thalidomide in Thalassemic PatientsCompletedNCT05132270Phase 2/3
• Selinexor in Combination With Thalidomide and Dexamethasone in RRMMStatus unknownNCT04891744Phase 1/2
• Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable BleedingStatus unknownNCT04680195Phase 2
• Comparison of BTD and BCD Based Regimens in the Treatment of AL AmyloidosisStatus unknownNCT04612582Phase 4
• The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19Status unknownNCT04273581Phase 2
• The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) PneumoniaStatus unknownNCT04273529Phase 2
• The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With MegestrolStatus unknownNCT03777930Phase 4
• Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent ThalassemiaCompletedNCT03651102Phase 2/3
• A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationWithdrawnNCT03608501Phase 2

← Thalidomide overview